AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

Moxifloxacin (Moxifloxacin Hydrochloride)

12 registrations across 1 African market— 12 active

Markets with Moxifloxacin (Moxifloxacin Hydrochloride)

Recent registrations

Brand / ProductMarketHolderStatusExpires
Vigamox Eyedrops**
Solution/Drops
🇳🇬NigeriaNovartis Nigeria LimitedactiveJul 2029
Moxifloxacin Tablets USP 400 mg
Tablet
🇳🇬NigeriaOnifam Laboratories LimitedactiveOct 2028
Moloxan Eye Drops
Eye drops
🇳🇬NigeriaSKT Healthcare Pharmaceuticals LtdactiveAug 2028
Micromox Eye Drops (incomplete smpc)
Eye drops
🇳🇬NigeriaMicro Nova Pharmaceuticals Ind LtdactiveJul 2028
Ketomox Eyedrops
Eye drops
🇳🇬NigeriaJagsol Health Care Nigeria LimitedactiveMay 2028
Bondmoxacin Eye Drop
Eye drops
🇳🇬NigeriaBond Chemical Industries LimitedactiveJan 2028
Avelox Intravenous Infusion**
Solution for infusion
🇳🇬NigeriaBayer Nigeria LimitedactiveDec 2026
Moxifloxacin Hydrochloride Eye Drops
Solution/Drops
🇳🇬NigeriaLin-Kabs Pharmaceutical LimitedactiveSept 2026
Moxifloxacin Ophthalmic Solution (strength format)
Eye drops
🇳🇬NigeriaMankind Life-Sciences LimitedactiveAug 2026
Nixin Tablet
Tablet
🇳🇬NigeriaHephzibah Pharmacy Nigeria LimitedactiveNov 2025
P-Moxin Tablets 400 mg
Tablet
🇳🇬NigeriaPinnacle Health Pharmaceutical & Stores LtdactiveNov 2025
Nixin Eye Drops
Solution/Drops
🇳🇬NigeriaHephzibah Pharmacy Nigeria LimitedactiveNov 2025

Moxifloxacin (Moxifloxacin Hydrochloride) in Africa — Regulatory Overview

Moxifloxacin (Moxifloxacin Hydrochloride) is registered across 1 African markets with 12 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Nigeria. AfricaRegulatory refreshes this data daily from official government sources.

Of the 12 registrations, 12 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.